Reiser K, Mathys L, Curbo S, Pannecouque C, Noppen S, Liekens S, et al. The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition. PLoS ONE. 2016;11:e0147773 pubmed publisher

Faghih M, Rostami Nejad M, Amani D, Sadeghi A, Pourhoseingholi M, Masotti A, et al. Analysis of IL17A and IL21 Expression in the Small Intestine of Celiac Disease Patients and Correlation with Circulating Thioredoxin Level. Genet Test Mol Biomarkers. 2018;22:518-525 pubmed publisher

Mahmoudian E, Khalilnezhad A, Gharagozli K, Amani D. Thioredoxin-1, redox factor-1 and thioredoxin-interacting protein, mRNAs are differentially expressed in Multiple Sclerosis patients exposed and non-exposed to interferon and immunosuppressive treatments. Gene. 2017;634:29-36 pubmed publisher

Lundberg M, Curbo S, Reiser K, Masterman T, Braesch Andersen S, Areström I, et al. Methodological aspects of ELISA analysis of thioredoxin 1 in human plasma and cerebrospinal fluid. PLoS ONE. 2014;9:e103554 pubmed publisher